- Home
- AUTL vs WEAV Comparison
AUTL vs WEAV Comparison
Compare AUTL & WEAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- WEAV
- Stock Information
- Founded
- AUTL 2014
- WEAV 2011
- Country
- AUTL United Kingdom
- WEAV United States
- Employees
- AUTL N/A
- WEAV N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- WEAV EDP Services
- Sector
- AUTL Health Care
- WEAV Technology
- Exchange
- AUTL Nasdaq
- WEAV Nasdaq
- Market Cap
- AUTL 625.4M
- WEAV 571.3M
- IPO Year
- AUTL 2018
- WEAV 2021
- Fundamental
- Price
- AUTL $1.38
- WEAV $7.70
- Analyst Decision
- AUTL Strong Buy
- WEAV Strong Buy
- Analyst Count
- AUTL 5
- WEAV 5
- Target Price
- AUTL $9.12
- WEAV $15.10
- AVG Volume (30 Days)
- AUTL 4.4M
- WEAV 915.4K
- Earning Date
- AUTL 11-11-2025
- WEAV 10-29-2025
- Dividend Yield
- AUTL N/A
- WEAV N/A
- EPS Growth
- AUTL N/A
- WEAV N/A
- EPS
- AUTL N/A
- WEAV N/A
- Revenue
- AUTL $29,934,000.00
- WEAV $220,834,000.00
- Revenue This Year
- AUTL $634.25
- WEAV $18.93
- Revenue Next Year
- AUTL $93.16
- WEAV $15.86
- P/E Ratio
- AUTL N/A
- WEAV N/A
- Revenue Growth
- AUTL 185.17
- WEAV 18.10
- 52 Week Low
- AUTL $1.11
- WEAV $6.75
- 52 Week High
- AUTL $5.00
- WEAV $17.63
- Technical
- Relative Strength Index (RSI)
- AUTL 28.28
- WEAV 49.31
- Support Level
- AUTL $1.34
- WEAV $7.58
- Resistance Level
- AUTL $1.46
- WEAV $8.00
- Average True Range (ATR)
- AUTL 0.09
- WEAV 0.24
- MACD
- AUTL 0.01
- WEAV 0.02
- Stochastic Oscillator
- AUTL 9.09
- WEAV 51.67
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About WEAV Weave Communications Inc.
Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.